These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12132367)

  • 1. [Barrett's esophagus].
    Dolina J; Hep A; Dítĕ P; Münzová H; Kunovská M; Husová L; Plottová Z
    Vnitr Lek; 2002 Jun; 48(6):587-90. PubMed ID: 12132367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Barrett's esophagus].
    Dolina J; Hep A; Dite P; Munzova H; Kunovska M; Husova L; Vlckova F; Pilottova Z
    Bratisl Lek Listy; 2000; 101(6):321-3. PubMed ID: 11039203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
    Jankowski JA; Anderson M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
    Sharma P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barrett's Esophagus.
    Pascu O; Lencu M
    Rom J Gastroenterol; 2004 Sep; 13(3):219-22. PubMed ID: 15470535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: towards consistency in the endoscopic diagnosis of Barrett's oesophagus and columnar metaplasia.
    Armstrong D
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():40-7; discussion 61-2. PubMed ID: 15456463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
    Todd JA; Basu KK; de Caestecker JS
    Aliment Pharmacol Ther; 2005 Apr; 21(8):969-75. PubMed ID: 15813832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus.
    Shalauta MD; Saad R
    Am Fam Physician; 2004 May; 69(9):2113-8. PubMed ID: 15152957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's esophagus: a review.
    Gadour M; Ayoola EA
    Trop Gastroenterol; 2002; 23(4):157-61. PubMed ID: 12833699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy.
    El-Serag HB; Aguirre T; Kuebeler M; Sampliner RE
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1255-60. PubMed ID: 15191506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux disease and Barrett's esophagus.
    Koop H
    Endoscopy; 2004 Feb; 36(2):103-9. PubMed ID: 14765307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evaluation of ablative therapy of Barrett's oesophagus.
    Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
    J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Barrett's esophagus: epidemiology diagnosis and treatment in 2005].
    Frossard JL; Dumonceau JM
    Rev Med Suisse; 2005 Sep; 1(31):2037-8, 2040-1. PubMed ID: 16212006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
    Cooper BT; Chapman W; Neumann CS; Gearty JC
    Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
    Fitzgerald RC
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.